Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...

Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa, in combination with the enzyme ...

This article on the best face exfoliators was updated after a second round of product testing with new face exfoliator picks ...

The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of ...

Sanofi reports positive phase 3 HERCULES study data for tolebrutinib in non-relapsing secondary progressive multiple sclerosis, showing a 31% delay in disability progression. Study also revealed ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...

Prof. Dr. Cecilia Van Cauwenberghe sheds light on sustainable chemistry, including how breakthrough innovations drive global ...

Ferulic Acid Market In 2022, the size of the world ferulic acid market was estimated to be worth US$ 67.8 million. By the end ...

The Albert Lasker Basic Medical Research Award went to Zhijian “James” Chen, University of Texas Southwestern Medical Center ...

Many of us have undergone a PCR (Polymerase Chain Reaction) or ELISA (Enzyme-Linked Immunosorbent Assay) test within the past four years. Yet these forms of testing are far from perfect. They require ...

A new study offers a fresh perspective on the role of sodium in mitochondrial physiology and points the way to future research into the relationship between complex I disorders and a host of neuronal ...